38112003: 1 (qualifier value)

Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2023. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

64719019 One en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3442105014 1 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
1	Is a	General adjectival modifier	false	Inferred relationship	Some
1	Is a	Number	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Baricitinib 2 mg oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Some
Baricitinib 2 mg oral tablet	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Baricitinib 4 mg oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Some
Baricitinib 4 mg oral tablet	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Calcium carbonate 900 mg/g cutaneous powder	Count of base of active ingredient	False	1	Inferred relationship	Some
Calcium carbonate 900 mg/g cutaneous powder	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely prednisolone acetate 1.2 milligram/1 milliliter conventional release suspension for eye drops (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely prednisolone acetate 1.2 milligram/1 milliliter conventional release suspension for eye drops (clinical drug)	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Product containing only calcium carbonate in cutaneous dose form (medicinal product form)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely pilocarpine nitrate 20 milligram/1 milliliter conventional release solution for eye drops (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely pilocarpine nitrate 20 milligram/1 milliliter conventional release solution for eye drops (clinical drug)	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely dihydrocodeine tartrate 10 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely dihydrocodeine tartrate 10 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Dihydrocodeine tartrate 2.42 mg/mL oral solution	Count of base of active ingredient	False	1	Inferred relationship	Some
Dihydrocodeine tartrate 2.42 mg/mL oral solution	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Hydroxocobalamin (as hydroxocobalamin chloride) 1 mg/mL solution for injection	Count of base of active ingredient	False	1	Inferred relationship	Some
Hydroxocobalamin (as hydroxocobalamin chloride) 1 mg/mL solution for injection	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Hydroxocobalamin (as hydroxocobalamin chloride) 1 mg/mL solution for injection	Has concentration strength numerator value	False	1	Inferred relationship	Some	1
Product containing precisely calcium acetate 500 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely calcium acetate 500 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Cabozantinib (as cabozantinib s-malate) 20 mg oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Some
Cabozantinib (as cabozantinib s-malate) 20 mg oral tablet	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely cabozantinib (as cabozantinib s-malate) 40 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely cabozantinib (as cabozantinib s-malate) 40 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Bilastine 20 mg oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Some
Bilastine 20 mg oral tablet	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing only bilastine in oral dose form (medicinal product form)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely cabozantinib (as cabozantinib s-malate) 60 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely cabozantinib (as cabozantinib s-malate) 60 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Bazedoxifene (as bazedoxifene acetate) 20 mg oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Some
Bazedoxifene (as bazedoxifene acetate) 20 mg oral tablet	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely azilsartan medoxomil (as azilsartan medoxomil potassium) 20 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely azilsartan medoxomil (as azilsartan medoxomil potassium) 20 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing only bazedoxifene in oral dose form (medicinal product form)	Count of base of active ingredient	False	1	Inferred relationship	Some
Bazedoxifene only product	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely avatrombopag (as avatrombopag maleate) 20 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely avatrombopag (as avatrombopag maleate) 20 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely tetracaine hydrochloride 10 milligram/1 milliliter conventional release solution for eye drops (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely tetracaine hydrochloride 10 milligram/1 milliliter conventional release solution for eye drops (clinical drug)	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely tetracaine hydrochloride 5 milligram/1 milliliter conventional release solution for eye drops (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely tetracaine hydrochloride 5 milligram/1 milliliter conventional release solution for eye drops (clinical drug)	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Benzyl benzoate 250 mg/mL cutaneous emulsion	Count of base of active ingredient	False	1	Inferred relationship	Some
Benzyl benzoate 250 mg/mL cutaneous emulsion	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 milliliter conventional release cutaneous solution (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 milliliter conventional release cutaneous solution (clinical drug)	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 milliliter conventional release cutaneous solution (clinical drug)	Has concentration strength numerator value	False	1	Inferred relationship	Some	1
Product containing precisely tocilizumab 20 milligram/1 milliliter conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely tocilizumab 20 milligram/1 milliliter conventional release solution for injection (clinical drug)	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Mifepristone 600 mg oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Some
Mifepristone 600 mg oral tablet	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely levocarnitine 300 milligram/1 milliliter conventional release oral solution (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely levocarnitine 300 milligram/1 milliliter conventional release oral solution (clinical drug)	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Nicotinic acid 500 mg oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Some
Nicotinic acid 500 mg oral capsule	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Atropine sulfate 200 microgram/mL solution for injection	Count of base of active ingredient	False	1	Inferred relationship	Some
Atropine sulfate 200 microgram/mL solution for injection	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely misoprostol 400 microgram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely misoprostol 400 microgram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Adrenaline 500 microgram/mL solution for injection	Count of base of active ingredient	False	1	Inferred relationship	Some
Adrenaline 500 microgram/mL solution for injection	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Clotrimazole 200 mg vaginal pessary	Count of base of active ingredient	False	1	Inferred relationship	Some
Clotrimazole 200 mg vaginal pessary	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely clotrimazole 500 milligram/1 each conventional release vaginal pessary (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely clotrimazole 500 milligram/1 each conventional release vaginal pessary (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely desmopressin acetate 100 microgram/1 milliliter conventional release solution for nasal drops (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely desmopressin acetate 100 microgram/1 milliliter conventional release solution for nasal drops (clinical drug)	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely ferrous sulfate 325 milligram/1 each prolonged-release oral tablet (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely ferrous sulfate 325 milligram/1 each prolonged-release oral tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Miconazole 20 mg/g oral gel	Count of base of active ingredient	False	1	Inferred relationship	Some
Miconazole 20 mg/g oral gel	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Calcium undecylenate 100 mg/g cutaneous powder	Count of base of active ingredient	False	1	Inferred relationship	Some
Calcium undecylenate 100 mg/g cutaneous powder	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely propamidine isethionate 1 milligram/1 milliliter conventional release solution for eye drops (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely propamidine isethionate 1 milligram/1 milliliter conventional release solution for eye drops (clinical drug)	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely propamidine isethionate 1 milligram/1 milliliter conventional release solution for eye drops (clinical drug)	Has concentration strength numerator value	False	1	Inferred relationship	Some	1
Product containing precisely lanolin alcohol 2 milligram/1 gram conventional release eye ointment (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely lanolin alcohol 2 milligram/1 gram conventional release eye ointment (clinical drug)	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Product containing only lanolin alcohol in ocular dose form (medicinal product form)	Count of base of active ingredient	False	1	Inferred relationship	Some
Acetylcysteine 600 mg effervescent oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Some
Acetylcysteine 600 mg effervescent oral tablet	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely Glycine max oil refined 200 milligram/1 milliliter conventional release emulsion for infusion (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely Glycine max oil refined 200 milligram/1 milliliter conventional release emulsion for infusion (clinical drug)	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely Glycine max oil refined 100 milligram/1 milliliter conventional release emulsion for infusion (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely Glycine max oil refined 100 milligram/1 milliliter conventional release emulsion for infusion (clinical drug)	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Product containing only Glycine max oil in parenteral dose form (medicinal product form)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing only carbon dioxide (medicinal product)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing only carbon dioxide in conventional release gas for inhalation (medicinal product form)	Count of base of active ingredient	False	1	Inferred relationship	Some
Helium only product in gas for inhalation	Count of base of active ingredient	False	1	Inferred relationship	Some
Oxygen only product in gas for inhalation	Count of base of active ingredient	False	1	Inferred relationship	Some
Vinflunine only product	Count of base of active ingredient	False	1	Inferred relationship	Some
Vinflunine only product in parenteral dose form	Count of base of active ingredient	False	1	Inferred relationship	Some
Alectinib (as alectinib hydrochloride) 150 mg oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Some
Alectinib (as alectinib hydrochloride) 150 mg oral capsule	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing only vandetanib in oral dose form (medicinal product form)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely vandetanib 100 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely vandetanib 100 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Vandetanib 300 mg oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Some
Vandetanib 300 mg oral tablet	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing only valrubicin in intravesical dose form (medicinal product form)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely neratinib (as neratinib maleate) 40 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely neratinib (as neratinib maleate) 40 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1

Start Previous Page 212 of 215 Next End

Reference Sets

Concept inactivation indicator reference set

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
64719019	One	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3442104013	1 (qualifier value)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3442105014	1	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core